TransMedics Group (TMDX) PT Lowered to $104 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Needham Downgrades TransMedics Group (TMDX) to Hold
November 22, 2024 5:01 AM ESTNeedham analyst Mike Matson downgraded TransMedics Group (NASDAQ: TMDX) from Buy to Hold.
The analyst comments "Our checks indicate that TMDX is facing intensifying competition from a variety of directions including OrganOx (private), Paragonix Technologies (GNGBY - Not Rated), and normothermic regional... More
